The company’s operating profit also dipped 4.4 percent from last year, ending the quarter at $241 million.
In its financial report, the orthopedic device manufacturer announced a $300 million share buyback program as part of a new “capital allocation framework.”
More Articles on Devices:
Smith & Nephew to Acquire India-Based Orthopedic Trauma Device Developer
NuVasive Gross Profits Up 4.9% in Q1
Alphatec Spine Gross Profits Increase 2.9% in Q1
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
